시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
스텐트 시장 규모, 점유율, 성장 분석 : 제품별, 소재별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Stents Market Size, Share, Growth Analysis, By Product (Vascular, Non-Vascular Stents), By Material (Metallic Stents, Non-Metallic Stents), By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1622471
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

스텐트 시장 규모는 2023년에 93억 달러로 평가되며, 2024년 96억 1,000만 달러에서 2032년에는 125억 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 3.3%로 성장할 전망입니다.

세계의 스텐트 시장은 CDC에 의하면 2019년에 약 360,900명의 사망으로 연결된 관상동맥 질환의 유병률 상승에 의해 촉진되어 큰 성장을 목격하고 있습니다. 이러한 급격한 성장은 스텐트 설계의 기술적 진보, 헬스케어 개발에 대한 민간 및 정부의 투자 증가, 약제용출 스텐트에 대한 수요 증가에 의해 주도되고 있습니다. 막힌 동맥의 혈류를 유지하는 데 필수적인 의료기기인 스텐트는 심혈관 질환뿐만 아니라 대동맥이나 뇌와 같은 중요한 부위의 동맥류 예방에도 활용되고 있습니다. 2021년 8월 시노메드가 유럽에서 출시한 HT Supreme 약물용출 스텐트는 업계의 끊임없는 혁신과 환자 니즈에 대한 대응을 강조하는 대표적인 사례입니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

스텐트 시장 규모 : 제품별

스텐트 시장 규모 : 소재별

스텐트 시장 규모 : 최종사용자별

스텐트 시장 규모

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Stents Market size was valued at USD 9.3 Billion in 2023 and is poised to grow from USD 9.61 Billion in 2024 to USD 12.5 Billion by 2032, growing at a CAGR of 3.3% during the forecast period (2025-2032).

The global stents market is witnessing significant growth driven by the rising prevalence of coronary artery disease, which led to approximately 360,900 deaths in 2019, according to the CDC. This surge is propelled by technological advancements in stent design, heightened investment from both private and government sources into healthcare development, and an escalating demand for drug-eluting stents. Stents, essential medical devices that maintain blood flow in blocked arteries, are increasingly being utilized not only for cardiovascular diseases but also for preventing aneurysms in critical areas like the aorta and brain. A notable example includes the European launch of the HT Supreme Drug-eluting stent by Sinomed in August 2021, highlighting the industry's continuous innovation and response to patient needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stents Market Segmental Analysis

Global Stents Market is segmented by product, material, end user and region. Based on product, the market is segmented into vascular and non-vascular stents. Based on material, the market is segmented into metallic stents and non-metallic stents. Based on end user, the market is segmented into hospitals, specialty clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stents Market

The stent market is significantly driven by the increasing global incidence of cardiovascular diseases (CVDs), which is anticipated to enhance market growth in the coming years. The rise in chronic disease cases is leading to greater demand for procedures such as percutaneous coronary interventions and peripheral vascular surgeries. The World Health Organization (WHO) reports that cardiovascular diseases result in approximately 17.9 million deaths annually, representing around 32% of all global fatalities. As the number of individuals affected by cardiovascular conditions continues to grow, it will inevitably heighten the need for stents, thereby propelling market demand.

Restraints in the Stents Market

One significant restraint on the stents market is the rigorous regulatory environment that hinders its growth potential. Various regulatory agencies, including the FDA, enforce stringent guidelines and requirements for the safe and effective use of stents. The FDA's thorough evaluation process necessitates a careful review of existing literature and pre-clinical animal studies prior to granting approval. This process is often resource-intensive, demanding considerable time and financial investment, particularly as coronary stents are classified as category III devices. Additionally, the classification of stents as medium to high-risk medical devices subjects them to stringent regulatory compliance, ultimately dampening market demand due to the complexity and costs associated with obtaining necessary approvals.

Market Trends of the Stents Market

The stents market is witnessing significant growth driven by continuous innovations and refinements in product design. Key advancements focus on optimizing stent features, such as reducing strut thickness, enhancing deliverability in complex vascular anatomies, and introducing a variety of lengths and diameters. Recent breakthroughs, like the FDA-approved Xience Sierra in 2018, emphasize enhanced flexibility and smaller profiles for improved performance during percutaneous coronary interventions (PCI). These developments aim to enhance patient outcomes and reduce procedural complications, thereby fueling market expansion. As healthcare providers increasingly adopt these advanced stent technologies, the market is poised for robust growth in the coming years.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Stents Market Size by Product & CAGR (2025-2032)

Global Stents Market Size by Material & CAGR (2025-2032)

Global Stents Market Size by End User & CAGR (2025-2032)

Global Stents Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기